96 related articles for article (PubMed ID: 8940217)
1. A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity.
Kum WW; Wood JA; Chow AW
J Infect Dis; 1996 Dec; 174(6):1261-70. PubMed ID: 8940217
[TBL] [Abstract][Full Text] [Related]
2. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
3. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.
Kum WW; Cameron SB; Hung RW; Kalyan S; Chow AW
Infect Immun; 2001 Dec; 69(12):7544-9. PubMed ID: 11705931
[TBL] [Abstract][Full Text] [Related]
4. A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.
Cullen CM; Blanco LR; Bonventre PF; Choi E
Infect Immun; 1995 Jun; 63(6):2141-6. PubMed ID: 7768593
[TBL] [Abstract][Full Text] [Related]
5. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
[TBL] [Abstract][Full Text] [Related]
6. Mutations affecting the activity of toxic shock syndrome toxin-1.
Deresiewicz RL; Woo J; Chan M; Finberg RW; Kasper DL
Biochemistry; 1994 Nov; 33(43):12844-51. PubMed ID: 7947690
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
Pontzer CH; Russell JK; Johnson HM
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes.
McCormick JK; Tripp TJ; Llera AS; Sundberg EJ; Dinges MM; Mariuzza RA; Schlievert PM
J Immunol; 2003 Aug; 171(3):1385-92. PubMed ID: 12874229
[TBL] [Abstract][Full Text] [Related]
9. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
Bonventre PF; Heeg H; Edwards CK; Cullen CM
Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids.
Gampfer JM; Samstag A; Waclavicek M; Wolf HM; Eibl MM; Gulle H
Vaccine; 2002 Nov; 20(31-32):3675-84. PubMed ID: 12399195
[TBL] [Abstract][Full Text] [Related]
11. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
13. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
14. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
[TBL] [Abstract][Full Text] [Related]
15. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm.
Stich N; Waclavicek M; Model N; Eibl MM
Toxins (Basel); 2010 Sep; 2(9):2272-88. PubMed ID: 22069685
[TBL] [Abstract][Full Text] [Related]
17. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
18. Separation of function between the domains of toxic shock syndrome toxin-1.
Wahlsten JL; Ramakrishnan S
J Immunol; 1998 Jan; 160(2):854-9. PubMed ID: 9551921
[TBL] [Abstract][Full Text] [Related]
19. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
20. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.
Woody MA; Krakauer T; Ulrich RG; Stiles BG
J Infect Dis; 1998 Apr; 177(4):1013-22. PubMed ID: 9534976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
